<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM RAYTEL
MEDICAL CORPORATION AND SUBSIDIARIES FINANCIAL STATEMENTS AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-01-1999
<PERIOD-END> SEP-30-2000
<CASH> 8,781
<SECURITIES> 0
<RECEIVABLES> 36,840<F1>
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 48,218
<PP&E> 48,540
<DEPRECIATION> 28,889
<TOTAL-ASSETS> 109,597
<CURRENT-LIABILITIES> 15,831
<BONDS> 0
0
0
<COMMON> 9
<OTHER-SE> 67,853
<TOTAL-LIABILITY-AND-EQUITY> 109,597
<SALES> 0
<TOTAL-REVENUES> 89,950
<CGS> 0
<TOTAL-COSTS> 86,407
<OTHER-EXPENSES> (186)
<LOSS-PROVISION> 0<F2>
<INTEREST-EXPENSE> 1,968
<INCOME-PRETAX> 1,761
<INCOME-TAX> 603
<INCOME-CONTINUING> 1,158
<DISCONTINUED> (4,960)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,802)
<EPS-BASIC> (0.44)
<EPS-DILUTED> (0.44)
<FN>
<F1>(RECEIVABLES) REPRESENTS NET RECEIVABLES
<F2>(LOSS PROVISION) INCLUDED IN (TOTAL COSTS)
</FN>
</TABLE>